Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Jeffery A. Anderson"'
Publikováno v:
Otology & Neurotology.
Autor:
Alan C. Foster, Stephanie Szobota, Fabrice Piu, Bonnie E. Jacques, David R. Moore, Victoria A. Sanchez, Jeffery J. Anderson
Publikováno v:
The Journal of the Acoustical Society of America. 151(6)
Currently, there are no approved medicines available for the treatment of hearing loss. However, research over the past two decades has contributed to a growing understanding of the pathological mechanisms in the cochlea that result in hearing diffic
Autor:
Kenneth S. Maxwell, Gordon McMurry, Jeffery J Anderson, Huiying J. Hou, David M. Baguley, Grant D. Searchfield, Ines Hoffmann, Fabrice Piu, James M Robinson
Publikováno v:
Otology & Neurotology
Objective: To evaluate the safety and exploratory efficacy of intratympanic administration of OTO-313 in patients with tinnitus. Study Design: Single intratympanic injection of OTO-313 evaluated in a randomized, double-blind, placebo-controlled Phase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d50feae90a93dbc6c01420ea4140490
Autor:
Donna M. Sylvester, Marcus S. Schamberger, Sara K. Pasquali, Subhadra Shashidharan, Danielle Hollenbeck-Pringle, Mark A. Scheurer, Brett R. Anderson, Kevin D. Hill, Marshall L. Jacobs, Evelyn G. Gotlieb, Brian W. McCrindle, Glenn J Pelletier, Jonathan R. Kaltman, Marko T. Boskovski, Felicia L. Trachtenberg, Kimberly E. McHugh, Jeffery B. Anderson, Aaron W. Eckhauser, Jeffrey P. Jacobs, Owen J. White, Carlos M. Mery, Jane W. Newburger, Meena Nathan
Publikováno v:
Cardiol Young
Background/Aims:Registry-based trials have emerged as a potentially cost-saving study methodology. Early estimates of cost savings, however, conflated the benefits associated with registry utilisation and those associated with other aspects of pragma
Autor:
Beshah Ayalew, Jeffery R. Anderson
Publikováno v:
Journal of Dynamic Systems, Measurement, and Control. 142
In the context of minimum-time vehicle maneuvering, previous works have shown that different professional drivers drive differently while achieving nearly identical performance. In this paper, a cascaded optimization framework is presented for modeli
Autor:
Jeffery B. Anderson, Melissa L. Morello, Gruschen R. Veldtman, Richard J. Czosek, Philip R. Khoury, David S. Spar, Timothy K. Knilans
Publikováno v:
Pacing and Clinical Electrophysiology. 41:472-479
Evaluate the efficacy, outcomes, and complications associated with direct current cardioversion (DCCV) in the treatment of arrhythmias in pediatric and adult congenital heart disease (CHD) populations and identify patient and procedural characteristi
Autor:
Jeffery R. Anderson, Beshah Ayalew
Publikováno v:
Vehicle System Dynamics. 56:1508-1531
In this paper, we explore the notion that a human driver uses a receding horizon model predictive control (MPC) scheme for minimum-time manoeuvering. However, MPC is an inherently sub-optimal contr...
Autor:
Manibarathi Vaithiyanathan, Adam T. Melvin, Ted J. Gauthier, Jeffery C. Anderson, Gavin A. Pappas, Nora Safa, Dong Liu, Jacob H. Pettigrew
Publikováno v:
Peptide science (Hoboken, N.J.). 111(2)
Cell penetrating peptides (CPPs) have emerged as powerful tools for delivering bioactive cargoes, such as biosensors or drugs to intact cells. One limitation of CPPs is their rapid degradation by intracellular proteases. β-hairpin "protectides" have
Autor:
Jeffery R. Anderson, Erin McPillan
Publikováno v:
Tire Science and Technology. 44:280-290
Optimization is a key tool used by automakers to efficiently design and manufacture vehicles. During vehicle design, much effort is devoted to efficiently simulate and optimize as many vehicle parameters as possible to save development costs during p
Autor:
Nicolas L. Madsen, Curt J. Daniels, Craig E. Fleishman, Kay Stewart-Huey, Robert M. Campbell, Jeffery B. Anderson, Robert N. Vincent, Stacey L. Lihn, Michael Gaies, Robert H. Beekman, Jeffrey P. Jacobs, Jean A. Connor, Devyani Chowdhury, John D. Kugler
Publikováno v:
Congenital heart disease. 13(2)
Pediatric cardiovascular services are responding to the dynamic changes in the medical environment, including the business of medicine. The opportunity to advance our pediatric cardiology field through collaboration is now realized, permitting us to